Bio-Rad's Q1 Nearly Flat on European Softness | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories reported after the close of the market on Tuesday that first quarter revenues were nearly flat year over year, as the company missed consensus Wall Street estimates on the top and bottom line.

For the three months ended March 31, revenues totaled $486.3 million, up a fraction of 1 percent from $485.1 million a year ago. Analyst estimates had revenues for the quarter at $492.4 million.

On a currency-neutral basis, revenues rose around 1 percent year over year, the company said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."